The Predictive Value of the EWGSOP Definition of Sarcopenia: Results from the InCHIANTI Study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 2, 2016, Pages 259-264

  Bianchi, Lara ^a   Ferrucci, Luigi ^b   Cherubini, Antonio ^c   Maggio, Marcello ^d   Bandinelli, Stefania ^e   Savino, Elisabetta ^a   Brombo, Gloria ^a   Zuliani, Giovanni ^a   Guralnik, Jack M ^f   Landi, Francesco ^g   Volpato, Stefano ^a,h  

^a UNIVERSITY OF FERRARA   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c INRCA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF FERRARA   (Italy)

Author keywords

Aging; Disability; Hospitalization; Mortality; Sarcopenia

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALGORITHM; BLOOD; DAILY LIFE ACTIVITY; DISABILITY; EPIDEMIOLOGY; FEMALE; GERIATRIC ASSESSMENT; HAND STRENGTH; HOSPITALIZATION; HUMAN; ITALY; MALE; MORTALITY; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; RISK FACTOR; SARCOPENIA; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOMARKERS; DISABILITY EVALUATION; FEMALE; GERIATRIC ASSESSMENT; HAND STRENGTH; HOSPITALIZATION; HUMANS; ITALY; MALE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SARCOPENIA;

EID: 84961618703     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv129     Document Type: Article

References (36)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990-991.
2. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-256. doi:10.1016/j.jamda.2011.01.003
3. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896.
4. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708-712.
5. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433-450.
6. Cruz-Jentoft A, Bayens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412-423. doi:10.1093/ageing/afq034
7. Spira D, Buchmann N, Nikolov J, et al. Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia - Data From the Berlin Aging Study II (BASE-II). J Gerontol A Biol Sci Med Sci. 2015;70(6): 779-784. doi:10.1093/gerona/glu246.
8. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985). 2003;95:1851-1860.
9. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005;60:324-333.
10. Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-159. doi:10.1016/j.clnu.2009.12.004
11. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12:403-409. doi:10.1016/j.jamda.2011.04.014
12. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547-558. doi:10.1093/gerona/glu010
13. Vetrano DL, Landi F, Volpato S, et al. Association of sarcopenia with short-and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci. 2014;69:1154-1161. doi:10.1093/gerona/glu034
14. Alexandre Tda S, Duarte YA, Santos JL, et al. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus Dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging. 2014;18:547-553. doi:10.1007/s12603-014-0450-3
15. McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69:576-583. doi:10.1093/gerona/glu012
16. Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: A systematic review. J Gerontol A Biol Sci Med Sci. 2013;68:39-46. doi:10.1093/gerona/gls174
17. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:567-575. doi:10.1093/gerona/glu023
18. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48: 1618-1625.
19. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89:465-471.
20. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159: 413-421.
21. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
22. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
23. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME, eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institute on Aging; 1995, NIH publ. no. 95-4009.
24. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69:438-446. doi:10.1093/gerona/glt149
25. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748-759. doi:10.1093/ageing/afu115
26. Cawthon PM, Fox KM, Gandra SR, et al. Do muscle mass, muscle density, strength and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57:1411-1419. doi:10.1111/j.1532-5415.2009.02366.x
27. Legrand D, Vaes B, Matheï C. Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old. J Am Geriatr Soc. 2014;62:1030-1038. doi:10.1111/jgs.12840
28. Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17:259-262. doi:10.1007/s12603-012-0434-0
29. Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42:203-209. doi:10.1093/ageing/afs194
30. Kim JH, Lim S, Choi SH, et al. Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men. J Gerontol A Biol Sci Med Sci. 2014;69:1244-1252. doi:10.1093/gerona/glu050
31. Alexandre Tda S, Duarte YA, Santos JL, et al. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 2014;18:751-756. doi:10.1007/s12603-014-0450-3
32. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc. 2012;13:121-126. doi:10.1016/j.jamda.2011.07.004
33. Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64:377-384. doi:10.1093/gerona/gln031
34. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72-77.
35. Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67:28-40. doi:10.1093/gerona/glr010
36. Savino E, Martini E, Lauretani F, et al. Handgrip strength predicts persistent walking recovery after hip fracture surgery. Am J Med. 2013;126:1068-75.e1. doi:10.1016/j.amjmed.2013.04.017